October 15, 2021
UCLA microbiology, immunology and molecular genetics professor Dr. Donald Kohn and his colleagues recently published a study that examined the results of a gene therapy they pioneered to treat children born with a rare and deadly immune system disorder. Nearly a decade out from receiving the therapy, 90% of patients remained disease-free. You can read the full UCLA Newsroom article, here.